UNCY regulatory event: a positive outcome, +8.3%

On October 20, 2026, Unicycive Therapeutics, Inc. reached its regulatory event. The result was a positive outcome, and the stock moved +8.3% in the window around the event. It had already run -30.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.